SEC Form D · Amendment · filed February 12, 2019
Viracta Therapeutics, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Standish Fleming · Cardiff, CADirectorBarry Simon · Cardiff, CADirectorIvor Royston · Cardiff, CAExec · DirectorDavid Slack · Cardiff, CAExecPatrick Soon-Shiong · Cardiff, CADirectorRichard Ghalie · Cardiff, CADirectorJames Woody · Cardiff, CADirectorKripa Varanasi · WOBURN, MADirectorMark Little · WOBURN, MADirectorClare F. Wood · London, United KingdomDirectorTerrence D. Yodaiken · London, United KingdomDirectorBritta P. Mccorduck · Charlotte, NCExecRajesh Unni · WOBURN, MAExec · DirectorSamuel Sichko · WOBURN, MADirectorFernando C. Verboonen · Rio de Janeiro, GuernseyDirectorWolney C. Betiol · Rio de Janeiro, GuernseyExecNelson Abrahao · Rio de Janeiro, GuernseyDirectorKen T. Denman · La Jolla, CAExec · DirectorLegendary Lodging VAB QOZ Manager, LLC · Fargo, NDDirectorAllen Faires · Columbus, OHDirectorAnthony Meyer · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗